109 related articles for article (PubMed ID: 18315457)
41. Risperidone-induced Pisa syndrome in MS: resolution with lurasidone and recurrence with Chlorpromazine.
Iuppa CA; Diefenderfer LA
Ann Pharmacother; 2013 Sep; 47(9):1223-8. PubMed ID: 24259741
[TBL] [Abstract][Full Text] [Related]
42. Management of a risperidone-induced tardive Pisa syndrome: a case report.
Kaufmann A; Boesch S; Fleischhacker WW; Hofer A
J Clin Psychopharmacol; 2012 Jun; 32(3):418-20. PubMed ID: 22561474
[No Abstract] [Full Text] [Related]
43. Treatment of generalized tardive dystonia with clozapine.
Aukst-Margetić B; Margetić B
Psychiatr Danub; 2008 Sep; 20(3):329-31. PubMed ID: 18827758
[TBL] [Abstract][Full Text] [Related]
44. Pisa syndrome induced by rapid increase and high dosage of risperidone.
Cordeiro Q; Zung S; Vallada H
Arq Neuropsiquiatr; 2008 Dec; 66(4):896-7. PubMed ID: 19099136
[No Abstract] [Full Text] [Related]
45. An n-of-1 trial service in clinical practice: testing the effectiveness of stimulants for attention-deficit/hyperactivity disorder.
Nikles CJ; Mitchell GK; Del Mar CB; Clavarino A; McNairn N
Pediatrics; 2006 Jun; 117(6):2040-6. PubMed ID: 16740846
[TBL] [Abstract][Full Text] [Related]
46. Risperidone-Associated Acute Laryngeal Dystonia: A Case Report.
Erdoğan A; İlhan F
J Clin Psychopharmacol; 2022 Jan-Feb 01; 42(1):98-99. PubMed ID: 34508055
[No Abstract] [Full Text] [Related]
47. Acute dystonia after initial doses of ziprasidone: a case report.
Yumru M; Savas HA; Selek S; Savas E
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):745-7. PubMed ID: 16580766
[TBL] [Abstract][Full Text] [Related]
48. A washout period needed before switching from a neuroleptic to an amphetamine.
Prescrire Int; 2009 Aug; 18(102):165. PubMed ID: 19743579
[TBL] [Abstract][Full Text] [Related]
49. Stimulant drug action in attention deficit hyperactivity disorder (ADHD): inference of neurophysiological mechanisms via quantitative modelling.
Rowe DL; Robinson PA; Gordon E
Clin Neurophysiol; 2005 Feb; 116(2):324-35. PubMed ID: 15661111
[TBL] [Abstract][Full Text] [Related]
50. Paroxysmal kinesigenic dystonia after methylphenidate administration.
Gay CT; Ryan SG
J Child Neurol; 1994 Jan; 9(1):45-6. PubMed ID: 8151081
[TBL] [Abstract][Full Text] [Related]
51. [Medication-induced mandibular luxation in a seven-year-old patient].
Willemsen MA; van der Wal KG
Tijdschr Psychiatr; 2008; 50(1):61-4. PubMed ID: 18188830
[TBL] [Abstract][Full Text] [Related]
52. Pharmacologic treatment of attention-deficit/hyperactivity disorder in children: incidence, prevalence, and treatment patterns in the Netherlands.
Hodgkins P; Sasané R; Meijer WM
Clin Ther; 2011 Feb; 33(2):188-203. PubMed ID: 21497704
[TBL] [Abstract][Full Text] [Related]
53. Emergence of tics in children with attention deficit hyperactivity disorder treated with stimulant medications.
Varley CK; Vincent J; Varley P; Calderon R
Compr Psychiatry; 2001; 42(3):228-33. PubMed ID: 11349243
[TBL] [Abstract][Full Text] [Related]
54. Medication-induced dystonias in nine patients with dementia.
Magnuson TM; Roccaforte WH; Wengel SP; Burke WJ
J Neuropsychiatry Clin Neurosci; 2000; 12(2):219-25. PubMed ID: 11001600
[TBL] [Abstract][Full Text] [Related]
55. The efficacy and safety profile of lisdexamfetamine dimesylate, a prodrug of d-amphetamine, for the treatment of attention-deficit/hyperactivity disorder in children and adults.
Najib J
Clin Ther; 2009 Jan; 31(1):142-76. PubMed ID: 19243715
[TBL] [Abstract][Full Text] [Related]
56. Prescribed stimulant use by Western Australians with Attention Deficit Hyperactivity Disorder (ADHD): does amount dispensed exceed the expected authorised use?
Calver J; Sanfilippo F; Preen D; Bulsara M
Aust N Z J Public Health; 2007 Dec; 31(6):533-9. PubMed ID: 18081573
[TBL] [Abstract][Full Text] [Related]
57. Pisa syndrome and laryngeal dystonia induced by novel antipsychotics.
Miodownik C; Lerner V; Witztum E
Isr J Psychiatry Relat Sci; 2011; 48(3):195-200. PubMed ID: 22141144
[TBL] [Abstract][Full Text] [Related]
58. Dexamphetamine normalises electrophysiological activity in attention deficit-hyperactivity disorder during the Stroop task.
Horrobin SL; McNair NA; Kirk IJ; Waldie KE
Neurocase; 2007 Oct; 13(5):301-10. PubMed ID: 18781428
[TBL] [Abstract][Full Text] [Related]
59. Psychosis associated with switching from risperidone to aripiprazole in an adolescent on methylphenidate treatment.
Ekinci O; Sabuncuoglu O
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):648-9. PubMed ID: 21134409
[No Abstract] [Full Text] [Related]
60. Dystonia with combined antipsychotic and stimulant treatment.
Levine JB; Deneys ML; Benjamin S
J Am Acad Child Adolesc Psychiatry; 2007 Jun; 46(6):665-666. PubMed ID: 17513979
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
